Literature DB >> 30021734

Rare cause for a common presentation: isolated pulmonary valve endocarditis yet another mimicker.

Ahmed Shameem Reza1, Dharmesh Anand2, Sing Huey Cheng3, Dharampal Anand3.   

Abstract

Isolated pulmonary valve endocarditis (PVE) is a rare condition. Known risk factors in previous case reports were intravenous drug abuse and congenital heart disease. Epidemiology of PVE has been changing. It is now being reported specially following invasive healthcare-related procedures even in patients with structurally normal heart. Vast majority of patients present with respiratory symptoms and diagnosis of endocarditis may be challenging unless there is high index of suspicion. Various microorganisms had been isolated as aetiological agents; however, Enterococcus faecalis is being increasingly isolated. PVE mostly managed conservatively with intravenous antibiotics with option for surgical intervention in specific situations. We present a patient with isolated PVE due to E. faecalis following colonoscopy and polypectomy with predisposing risk factor of alcohol excess, mimicking clinically as pneumonia and radiologically as a neoplastic lesion. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  nosocomial infections; valvar diseases

Mesh:

Substances:

Year:  2018        PMID: 30021734     DOI: 10.1136/bcr-2018-224703

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

1.  Isolated Pulmonic Valve Endocarditis: Case Report and Review of Existing Literature on Diagnosis and Therapy.

Authors:  Maryam Saleem; Fatima Ahmed; Kinjan Patel; Muhamad Bilal Munir; Yasir Abdul Ghaffar; Hassan Mujahid; Sudarshan Balla
Journal:  CASE (Phila)       Date:  2019-07-19

Review 2.  Isolated pulmonary valve endocarditis with rapid progression: a case report and literature review.

Authors:  Ming-Xuan Zhang; Wei-Min Zhang; Chan Yu; Bo-Wen Zhao; Ran Chen; Mei Pan; Bei Wang
Journal:  J Cardiothorac Surg       Date:  2021-01-28       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.